Describes Emil Freireich's research into drugs to treat acute lymphoblastic leukemia (ALL) in the nineteen-fifties and sixties.

NEWYORKER: The Treatment

The patients, who ranged in age from 23 to 66, were diagnosed with acute lymphoblastic leukemia, or ALL, and had previously relapsed after standard chemotherapy.

WSJ: Gene Therapy Shows Promise as Cancer Treatment